JLE

Epileptic Disorders

MENU

Acute symptomatic seizures: an educational, evidence-based review Volume 24, issue 1, February 2022

  • [1] Hauser W.A., Beghi E. First seizure definitions and worldwide incidence and mortality. Epilepsia. 2008;49:8-12. 1
  • [2] Blümcke I., Arzimanoglou A., Beniczky S., Wiebe S. Roadmap for a competency-based educational curriculum in epileptology: report of the Epilepsy Education Task Force of the International League Against Epilepsy. Epileptic Disord. 2019;21:129-140. 2
  • [3] Fisher R.S., van Emde Boas W., Blume W., Elger C., Genton P., Lee P. Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia. 2005;46:470-472. 4
  • [4] Fisher R.S., Acevedo C., Arzimanoglou A., Bogacz A., Cross J.H., Elger C.E. ILAE official report: a practical clinical definition of epilepsy. Epilepsia. 2014;55:475-482. 4
  • [5] Beghi E., Carpio A., Forsgren L., Hesdorffer D.C., Malmgren K., Sander J.W. Recommendation for a definition of acute symptomatic seizure. Epilepsia. 2010;51:671-675. 4
  • [6] Camfield P., Camfield C. Febrile seizures and genetic epilepsy with febrile seizures plus (GEFS). Epileptic Disord. 2015;17:124-133. +2
  • [7] Shorvon S. The concept of symptomatic epilepsy and the complexities of assigning cause in epilepsy. Epilepsy Behav. 2014;32:1-8.
  • [8] Hesdorffer D.C., Benn E.K., Cascino G.D., Hauser W.A. Is a first acute symptomatic seizure epilepsy? Mortality and risk for recurrent seizure. Epilepsia. 2009;50:1102-1108. 5
  • [9] Galovic M., Döhler N., Erdélyi-Canavese B., Felbecker A., Siebel P., Conrad J. Prediction of late seizures after ischaemic stroke with a novel prognostic model (the SeLECT score): a multivariable prediction model development and validation study. Lancet Neurol. 2018;17:143-152. 2
  • [10] Nardone R., Brigo F., Trinka E. Acute symptomatic seizures caused by electrolyte disturbances. J Clin Neurol. 2016;12:21-33. 1
  • [11] Hauser W.A., Annegers J.F., Rocca W.A. Descriptive epidemiology of epilepsy: contributions of population-based studies from Rochester, Minnesota. Mayo Clin Proc. 1996;71:576-586. 6
  • [12] Annegers J.F., Hauser W.A., Lee J.R., Rocca W.A. Incidence of acute symptomatic seizures in Rochester, Minnesota, 1935-1984. Epilepsia. 1995;36:327-333. 4
  • [13] Loiseau J., Loiseau P., Guyot M., Duche B., Dartigues J.F., Aublet B. Survey of seizure disorders in the French southwest. I. Incidence of epileptic syndromes. Epilepsia. 1990;31:391-396. 4
  • [14] Jallon P., Goumaz M., Haenggeli C., Morabia A. Incidence of first epileptic seizures in the canton of Geneva, Switzerland. Epilepsia. 1997;38:547-552. 5
  • [15] Forsgren L., Bucht G., Eriksson S., Bergmark L. Incidence and clinical characterization of unprovoked seizures in adults: a prospective population-based study. Epilepsia. 1996;37:224-229. 3
  • [16] Hesdorffer D.C., D’Amelio M. Mortality in the first 30 days following incident acute symptomatic seizures. Epilepsia. 2005;46:43-45. Suppl 11
  • [17] Fields M.C., Labovitz D.L., French J.A. Hospital-onset seizures: an inpatient study. JAMA Neurol. 2013;70:360-364. 3
  • [18] Logroscino G., Hesdorffer D.C., Cascino G., Annegers J.F., Hauser W.A. Short-term mortality after a first episode of status epilepticus. Epilepsia. 1997;38:1344-1349. 12
  • [19] Logroscino G., Hesdorffer D.C., Cascino G.D., Annegers J.F., Bagiella E., Hauser W.A. Long-term mortality after a first episode of status epilepticus. Neurology. 2002;58:537-541. 4
  • [20] Arboix A., Comes E., Massons J., García L., Oliveres M. Relevance of early seizures for in-hospital mortality in acute cerebrovascular disease. Neurology. 1996;47:1429-1435. 6
  • [21] Labovitz D.L., Hauser W.A., Sacco R.L. Prevalence and predictors of early seizure and status epilepticus after first stroke. Neurology. 2001;57:200-206. 2
  • [22] Zöllner J.P., Misselwitz B., Kaps M., Stein M., Konczalla J., Roth C. National Institutes of Health Stroke Scale (NIHSS) on admission predicts acute symptomatic seizure risk in ischemic stroke: a population-based study involving 135,117 cases. Sci Rep. 2020;10:3779. 1
  • [23] Berg A.T., Shinnar S. The risk of seizure recurrence following a first unprovoked seizure: a quantitative review. Neurology. 1991;41:965-972. 7
  • [24] Hauser W.A., Rich S.S., Lee J.R., Annegers J.F., Anderson V.E. Risk of recurrent seizures after two unprovoked seizures. N Engl J Med. 1998;338:429-434. 7
  • [25] Krumholz A., Wiebe S., Gronseth G.S., Gloss D.S., Sanchez A.M., Kabir A.A. Evidence-based guideline: management of an unprovoked first seizure in adults: report of the guideline development subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology. 2015;84:1705-1713. 16
  • [26] Beghi E., D’Alessandro R., Beretta S., Consoli D., Crespi V., Delaj L. Incidence and predictors of acute symptomatic seizures after stroke. Neurology. 2011;77:1785-1793. 20
  • [27] Stefanidou M., Das R.R., Beiser A.S., Sundar B., Kelly-Hayes M., Kase C.S. Incidence of seizures following initial ischemic stroke in a community-based cohort: the Framingham Heart Study. Seizure. 2017;47:105-110.
  • [28] Silverman I.E., Restrepo L., Mathews G.C. Poststroke seizures. Arch Neurol. 2002;59:195-201. 2
  • [29] Camilo O., Goldstein L.B. Seizures and epilepsy after ischemic stroke. Stroke. 2004;35:1769-1775. 7
  • [30] De Herdt V., Dumont F., Hénon H., Derambure P., Vonck K., Leys D. Early seizures in intracerebral hemorrhage: incidence, associated factors, and outcome. Neurology. 2011;77:1794-1800. 20
  • [31] Bladin C.F., Alexandrov A.V., Bellavance A., Bornstein N., Chambers B., Coté R. Seizures after stroke: a prospective multicenter study. Arch Neurol. 2000;57:1617-1622. 11
  • [32] Feher G., Gurdan Z., Gombos K., Koltai K., Pusch G., Tibold A. Early seizures after ischemic stroke: focus on thrombolysis. CNS Spectr. 2020;25:101-113. 1
  • [33] Zöllner J.P., Konczalla J., Stein M., Roth C., Krakow K., Kaps M. Acute symptomatic seizures in intracerebral and subarachnoid hemorrhage: a population study of 19331 patients. Epilepsy Res. 2020;161:106286.
  • [34] Bentes C., Brigo F., Zelano J., Ferro J.M. Reperfusion therapies and poststroke seizures. Epilepsy Behav. 2020;104:106524. Pt B
  • [35] Naylor J., Thevathasan A., Churilov L., Guo R., Xiong Y., Koome M. Association between different acute stroke therapies and development of post stroke seizures. BMC Neurol. 2018;18:61. 1
  • [36] Belcastro V., Brigo F., Ferlazzo E., Gasparini S., Mastroianni G., Cianci V. Incidence of early poststroke seizures during reperfusion therapies in patients with acute ischemic stroke: an observational prospective study: (TESI study: “Trombolisi/Trombectomia e crisi Epilettiche precoci nello Stroke Ischemico”). Epilepsy Behav. 2020;104:106476. Pt B
  • [37] Brigo F., Schneider M., Wagenpfeil G., Ragoschke-Schumm A., Fousse M., Holzhoffer C. Intravenous thrombolysis with tPA and cortical involvement increase the risk of early poststroke seizures: Results of a case-control study. Epilepsy Behav. 2020;104:106312. Pt B
  • [38] De Reuck J., Goethals M., Claeys I., Van Maele G., De Clerck M. EEG findings after a cerebral territorial infarct in patients who develop early- and late-onset seizures. Eur Neurol. 2006;55:209-213. 4
  • [39] Pohlmann-Eden B., Hoch D.B., Cochius J.I., Chiappa K.H. Periodic lateralized epileptiform discharges - a critical review. J Clin Neurophysiol. 1996;13:519-530. 6
  • [40] Hartings J.A., Williams A.J., Tortella F.C. Occurrence of nonconvulsive seizures, periodic epileptiform discharges, and intermittent rhythmic delta activity in rat focal ischemia. Exp Neurol. 2003;179:139-149. 2
  • [41] Abraira L., Giannini N., Santamarina E., Cazorla S., Bustamante A., Quintana M. Correlation of blood biomarkers with early-onset seizures after an acute stroke event. Epilepsy Behav. 2020;104:106549. Pt B
  • [42] Serafini A., Gigli G.L., Gregoraci G., Janes F., Cancelli I., Novello S. Are early seizures predictive of epilepsy after a stroke? Results of a population-based study. Neuroepidemiology. 2015;45:50-58. 1
  • [43] Holtkamp M., Beghi E., Benninger F., Kälviäinen R., Rocamora R., Christensen H. European Stroke Organisation guidelines for the management of post-stroke seizures and epilepsy. Eur Stroke J. 2017;2:103-115. 2
  • [44] Ferro J.M., Canhão P., Bousser M.G., Stam J., Barinagarrementeria F. Early seizures in cerebral vein and dural sinus thrombosis: risk factors and role of antiepileptics. Stroke. 2008;39:1152-1158. 4
  • [45] Ferro J.M., Aguiar de Sousa D. Cerebral venous thrombosis: an update. Curr Neurol Neurosci Rep. 2019;19:74. 10
  • [46] Kalita J., Misra U.K., Singh V.K., Dubey D. Predictors and outcome of status epilepticus in cerebral venous thrombosis. J Neurol. 2019;266:417-425. 2
  • [47] Lindgren E., Silvis S.M., Hiltunen S., Heldner M.R., Serrano F., de Scisco M. Acute symptomatic seizures in cerebral venous thrombosis. Neurology. 2020;95:e1706-e1715. 12
  • [48] Annegers J.F., Hauser W.A., Beghi E., Nicolosi A., Kurland L.T. The risk of unprovoked seizures after encephalitis and meningitis. Neurology. 1988;38:1407-1410. 9
  • [49] Kim M.A., Park K.M., Kim S.E., Oh M.K. Acute symptomatic seizures in CNS infection. Eur J Neurol. 2008;15:38-41. 1
  • [50] Misra U.K., Kalita J. Seizures in encephalitis: predictors and outcome. Seizure. 2009;18:583-587. 8
  • [51] Holtkamp M., Othman J., Buchheim K., Meierkord H. Predictors and prognosis of refractory status epilepticus treated in a neurological intensive care unit. J Neurol Neurosurg Psychiatry. 2005;76:534-539. 4
  • [52] Michael B.D., Solomon T. Seizures and encephalitis: clinical features, management, and potential pathophysiologic mechanisms. Epilepsia. 2012;53:63-71. Suppl 4
  • [53] Solomon T., Dung N.M., Kneen R., Thao le T.T., Gainsborough M., Nisalak A. Seizures and raised intracranial pressure in Vietnamese patients with Japanese encephalitis. Brain. 2002;125:1084-1093. Pt 5
  • [54] Sellner J, Trinka E. Epilepsy associated with viral encephalitis. In: Shorvon S, Guerrini R, Schachter S, Trinka E. (ed.) The causes of epilepsy. 2nd edition. Cambridge, England: Cambridge University Press, 2019.
  • [55] Misra U.K., Tan C.T., Kalita J. Viral encephalitis and epilepsy. Epilepsia. 2008;49:13-18. Suppl 6
  • [56] Chen S.F., Huang C.C., Wu H.M., Chen S.H., Liang Y.C., Hsu K.S. Seizure, neuron loss, and mossy fiber sprouting in herpes simplex virus type 1-infected organotypic hippocampal cultures. Epilepsia. 2004;45:322-332. 4
  • [57] Vezzani A., Fujinami R.S., White H.S., Preux P.M., Blümcke I., Sander J.W. Infections, inflammation and epilepsy. Acta Neuropathol. 2016;131:211-234. 2
  • [58] Pomeroy S.L., Holmes S.J., Dodge P.R., Feigin R.D. Seizures and other neurologic sequelae of bacterial meningitis in children. N Engl J Med. 1990;323:1651-1657. 24
  • [59] Corrêa-Lima A.R., de Barros Miranda-Filho D., Valença M.M., Andrade-Valença L. Risk factors for acute symptomatic seizure in bacterial meningitis in children. J Child Neurol. 2015;30:1182-1185. 9
  • [60] Zoons E., Weisfelt M., de Gans J., Spanjaard L., Koelman J.H., Reinsma J.B. Seizures in adults with bacterial meningitis. Neurology. 2008;70:2109-2115. 22 Pt 2
  • [61] Wang K.W., Chang W.N., Chang H.W., Chuang Y.C., Tsai N.W., Wang H.C. The significance of seizures and other predictive factors during the acute illness for the long-term outcome after bacterial meningitis. Seizure. 2005;14:586-592. 8
  • [62] Durand M.L., Calderwood S.B., Weber D.J., Miller S.I., Southwick F.S., Caviness V.S. Jr. Acute bacterial meningitis in adults. A review of 493 episodes. N Engl J Med. 1993;328:21-28. 1
  • [63] Brouwer M.C., Coutinho J.M., van de Beek D. Clinical characteristics and outcome of brain abscess: systematic review and meta-analysis. Neurology. 2014;82:806-813. 9
  • [64] Crawley J., Smith S., Muthinji P., Marsh K., Kirkham F. Electroencephalographic and clinical features of cerebral malaria. Arch Dis Child. 2001;84:247-253. 3
  • [65] Carpio A. Neurocysticercosis: an update. Lancet Infect Dis. 2002;2:751-762. 12
  • [66] Carpio A., Fleury A., Hauser W.A. Neurocysticercosis: five new things. Neurol Clin Pract. 2013;3:118-125. 2
  • [67] Nash T.E., Del Brutto O.H., Butman J.A., Corona T., Delgado-Escueta A., Duron R.M. Calcific neurocysticercosis and epileptogenesis. Neurology. 2004;62:1934-1938. 11
  • [68] Satishchandra P., Sinha S. Seizures in HIV-seropositive individuals: NIMHANS experience and review. Epilepsia. 2008;49:33-41. Suppl 6
  • [69] Wong M.C., Suite N.D., Labar D.R. Seizures in human immunodeficiency virus infection. Arch Neurol. 1990;47:640-642. 6
  • [70] Kellinghaus C., Engbring C., Kovac S., Möddel G., Boesebeck F., Fischera M. Frequency of seizures and epilepsy in neurological HIV-infected patients. Seizure. 2008;17:27-33. 1
  • [71] Graus F., Titulaer M.J., Balu R., Benseler S., Bien C.G., Cellucci T. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol. 2016;15:391-404. 4
  • [72] Geis C., Planagumà J., Carreño M., Graus F., Dalmau J. Autoimmune seizures and epilepsy. J Clin Invest. 2019;129:926-940. 3
  • [73] Dalmau J., Graus F. Antibody-mediated encephalitis. N Engl J Med. 2018;378:840-851. 9
  • [74] Gaspard N., Foreman B.P., Alvarez V., Cabrera Kang C., Probasco J.C., Jongeling A.C. New-onset refractory status epilepticus: etiology, clinical features, and outcome. Neurology. 2015;85:1604-1613. 18
  • [75] Koch M., Uyttenboogaart M., Polman S., De Keyser J. Seizures in multiple sclerosis. Epilepsia. 2008;49:948-953. 6
  • [76] Vincent A., Crino P.B. Systemic and neurologic autoimmune disorders associated with seizures or epilepsy. Epilepsia. 2011;52:12-17. Suppl 3
  • [77] Sokic D.V., Stojsavljevic N., Drulovic J., Dujmovic I., Mesaros S., Ercegovac M. Seizures in multiple sclerosis. Epilepsia. 2001;42:72-79. 1
  • [78] Devinsky O., Schein A., Najjar S. Epilepsy associated with systemic autoimmune disorders. Epilepsy Curr. 2013;13:62-68. 2
  • [79] Appenzeller S., Cendes F., Costallat L.T. Epileptic seizures in systemic lupus erythematosus. Neurology. 2004;63:1808-1812. 10
  • [80] Laurent C., Capron J., Quillerou B., Thomas G., Alamowitch S., Fain O. Steroid-responsive encephalopathy associated with autoimmune thyroiditis (SREAT): characteristics, treatment and outcome in 251 cases from the literature. Autoimmun Rev. 2016;15:1129-1133. 12
  • [81] Tyler K.L., Rüegg S. The neuromythology of Hashimoto encephalopathy: the emperor has no clothes. Neurology. 2020;94:55-56. 2
  • [82] Mattozzi S., Sabater L., Escudero D., Ariño H., Armangue T., Simabukuro M. Hashimoto encephalopathy in the 21st century. Neurology. 2020;94:e217-e224. 2
  • [83] Temkin N.R. Risk factors for posttraumatic seizures in adults. Epilepsia. 2003;44:18-20. s10
  • [84] Ritter A.C., Wagner A.K., Fabio A., Pugh M.J., Walker W.C., Szaflarski J.P. Incidence and risk factors of posttraumatic seizures following traumatic brain injury: a traumatic brain injury model systems study. Epilepsia. 2016;57:1968-1977. 12
  • [85] Wilson C.D., Burks J.D., Rodgers R.B., Evans R.M., Bakare A.A., Safavi-Abbasi S. Early and late posttraumatic epilepsy in the setting of traumatic brain injury: a meta-analysis and review of antiepileptic management. World Neurosurg. 2018;110:e901-e906.
  • [86] McCrory P.R., Bladin P.F., Berkovic S.F. Retrospective study of concussive convulsions in elite Australian rules and rugby league footballers: phenomenology, aetiology, and outcome. Bmj. 1997;314:171-174. 7075
  • [87] Xu T., Yu X., Ou S., Liu X., Yuan J., Huang H. Risk factors for posttraumatic epilepsy: a systematic review and meta-analysis. Epilepsy Behav. 2017;67:1-6.
  • [88] Kim J.A., Boyle E.J., Wu A.C., Cole A.J., Staley K.J., Zafar S. Epileptiform activity in traumatic brain injury predicts post-traumatic epilepsy. Ann Neurol. 2018;83:858-862. 4
  • [89] Perucca P., Smith G., Santana-Gomez C., Bragin A., Staba R. Electrophysiological biomarkers of epileptogenicity after traumatic brain injury. Neurobiol Dis. 2019;123:69-74.
  • [90] Duncan D., Vespa P., Pitkänen A., Braimah A., Lapinlampi N., Toga A.W. Big data sharing and analysis to advance research in post-traumatic epilepsy. Neurobiol Dis. 2019;123:127-136.
  • [91] Herman S.T., Abend N.S., Bleck T.P., Chapman K.E., Drislane F.W., Emerson R.G. Consensus statement on continuous EEG in critically ill adults and children, part I: indications. J Clin Neurophysiol. 2015;32:87-95. 2
  • [92] Claassen J., Mayer S.A., Kowalski R.G., Emerson R.G., Hirsch L.J. Detection of electrographic seizures with continuous EEG monitoring in critically ill patients. Neurology. 2004;62:1743-1748. 10
  • [93] Limotai C., Ingsathit A., Thadanipon K., McEvoy M., Attia J., Thakkinstian A. How and whom to monitor for seizures in an icu: a systematic review and meta-analysis. Crit Care Med. 2019;47:e366-e373. 4
  • [94] Zafar S.F., Subramaniam T., Osman G., Herlopian A., Struck A.F. Electrographic seizures and ictal-interictal continuum (IIC) patterns in critically ill patients. Epilepsy Behav. 2020;106:107037.
  • [95] Newey C.R., Kinzy T.G., Punia V., Hantus S. Continuous electroencephalography in the critically Ill: clinical and continuous electroencephalography markers for targeted monitoring. J Clin Neurophysiol. 2018;35:325-331. 4
  • [96] Vespa P.M., Nenov V., Nuwer M.R. Continuous EEG monitoring in the intensive care unit: early findings and clinical efficacy. J Clin Neurophysiol. 1999;16:1-13. 1
  • [97] Vespa P.M., McArthur D.L., Xu Y., Eliseo M., Etchepare M., Dinov I. Nonconvulsive seizures after traumatic brain injury are associated with hippocampal atrophy. Neurology. 2010;75:792-798. 9
  • [98] Wagenman K.L., Blake T.P., Sanchez S.M., Schultheis M.T., Radcliffe J., Berg R.A. Electrographic status epilepticus and long-term outcome in critically ill children. Neurology. 2014;82:396-404. 5
  • [99] De Marchis G.M., Pugin D., Meyers E., Velasquez A., Suwatcharangkoon S., Park S. Seizure burden in subarachnoid hemorrhage associated with functional and cognitive outcome. Neurology. 2016;86:253-260. 3
  • [100] Payne E.T., Zhao X.Y., Frndova H., McBain K., Sharma R., Hutchison J.S. Seizure burden is independently associated with short term outcome in critically ill children. Brain. 2014;137:1429-1438. Pt 5
  • [101] Löscher W., Hirsch L.J., Schmidt D. The enigma of the latent period in the development of symptomatic acquired epilepsy - traditional view versus new concepts. Epilepsy Behav. 2015;52:78-92. Pt A
  • [102] Punia V., Fitzgerald Z., Zhang X., Huynh H., Bena J., Morrison S. Electroencephalographic biomarkers of epilepsy development in patients with acute brain injury: a matched, parallel cohort study. Ann Clin Transl Neurol. 2019;6:2230-2239. 11
  • [103] Punia V., Bena J., Krishnan B., Newey C., Hantus S. New onset epilepsy among patients with periodic discharges on continuous electroencephalographic monitoring. Epilepsia. 2018;59:1612-1620. 8
  • [104] Castilla-Guerra L., del Carmen Fernández-Moreno M., López-Chozas J.M., Fernández-Bolaños R. Electrolytes disturbances and seizures. Epilepsia. 2006;47:1990-1998. 12
  • [105] Imad H., Zelano J., Kumlien E. Hypoglycemia and risk of seizures: a retrospective cross-sectional study. Seizure. 2015;25:147-149.
  • [106] Lammouchi T., Zoghlami F., Ben Slamia L., Grira M., Harzallah M.S., Benammou S. Epileptic seizures in non-ketotic hyperglycemia. Neurophysiol Clin. 2004;34:183-187. 3-4
  • [107] McLauchlan D.J., Powell R. Acute symptomatic seizures. Pract Neurol. 2012;12:154-165. 3
  • [108] Derle E., Kibaroğlu S., Öcal R., Kırnap M., Kılınç M., Benli S. Seizure as a neurologic complication after liver transplant. Exp Clin Transplant. 2015;13:323-326. Suppl 1
  • [109] Pesola G.R., Avasarala J. Bupropion seizure proportion among new-onset generalized seizures and drug related seizures presenting to an emergency department. J Emerg Med. 2002;22:235-239. 3
  • [110] Finkelstein Y., Hutson J.R., Freedman S.B., Wax P., Brent J. Drug-induced seizures in children and adolescents presenting for emergency care: current and emerging trends. Clin Toxicol (Phila). 2013;51:761-766. 8
  • [111] Thundiyil J.G., Kearney T.E., Olson K.R. Evolving epidemiology of drug-induced seizures reported to a Poison Control Center System. J Med Toxicol. 2007;3:15-19. 1
  • [112] Reichert C., Reichert P., Monnet-Tschudi F., Kupferschmidt H., Ceschi A., Rauber-Lüthy C. Seizures after single-agent overdose with pharmaceutical drugs: analysis of cases reported to a poison center. Clin Toxicol (Phila). 2014;52:629-634. 6
  • [113] Devinsky O., Honigfeld G., Patin J. Clozapine-related seizures. Neurology. 1991;41:369-371. 3
  • [114] Payne L.E., Gagnon D.J., Riker R.R., Seder D.B., Glisic E.K., Morris J.G. Cefepime-induced neurotoxicity: a systematic review. Crit Care. 2017;21:276. 1
  • [115] Cannon J.P., Lee T.A., Clark N.M., Setlak P., Grim S.A. The risk of seizures among the carbapenems: a meta-analysis. J Antimicrob Chemother. 2014;69:2043-2055. 8
  • [116] Sutter R., Rüegg S., Tschudin-Sutter S. Seizures as adverse events of antibiotic drugs: a systematic review. Neurology. 2015;85:1332-1341. 15
  • [117] Walder B., Tramèr M.R., Seeck M. Seizure-like phenomena and propofol: a systematic review. Neurology. 2002;58:1327-1332. 9
  • [118] Zubair S., Patton T., Smithson K., Sonmezturk H.H., Arain A., Abou-Khalil B. Propofol withdrawal seizures: non-epileptic nature of seizures in a patient with recently controlled status epilepticus. Epileptic Disord. 2011;13:107-110. 1
  • [119] Chen H.Y., Albertson T.E., Olson K.R. Treatment of drug-induced seizures. Br J Clin Pharmacol. 2016;81:412-419. 3
  • [120] Bråthen G., Ben-Menachem E., Brodtkorb E., Galvin R., Garcia-Monco J.C., Halasz P. EFNS guideline on the diagnosis and management of alcohol-related seizures: report of an EFNS task force. Eur J Neurol. 2005;12:575-581. 8
  • [121] Hughes J.R. Alcohol withdrawal seizures. Epilepsy Behav. 2009;15:92-97. 2
  • [122] Rathlev N.K., Ulrich A., Shieh T.C., Callum M.G., Bernstein E., D’Onofrio G. Etiology and weekly occurrence of alcohol-related seizures. Acad Emerg Med. 2002;9:824-828. 8
  • [123] Fugate J.E., Rabinstein A.A. Posterior reversible encephalopathy syndrome: clinical and radiological manifestations, pathophysiology, and outstanding questions. Lancet Neurol. 2015;14:914-925. 9
  • [124] Hinchey J., Chaves C., Appignani B., Breen J., Pao L., Wang A. A reversible posterior leukoencephalopathy syndrome. N Engl J Med. 1996;334:494-500. 8
  • [125] Kastrup O., Gerwig M., Frings M., Diener H.C. Posterior reversible encephalopathy syndrome (PRES): electroencephalographic findings and seizure patterns. J Neurol. 2012;259:1383-1389. 7
  • [126] Bakshi R., Bates V.E., Mechtler L.L., Kinkel P.R., Kinkel W.R. Occipital lobe seizures as the major clinical manifestation of reversible posterior leukoencephalopathy syndrome: magnetic resonance imaging findings. Epilepsia. 1998;39:295-299. 3
  • [127] Kozak O.S., Wijdicks E.F., Manno E.M., Miley J.T., Rabinstein A.A. Status epilepticus as initial manifestation of posterior reversible encephalopathy syndrome. Neurology. 2007;69:894-897. 9
  • [128] Bastide L., Legros B., Rampal N., Gilmore E.J., Hirsch L.J., Gaspard N. Clinical correlates of periodic discharges and nonconvulsive seizures in Posterior Reversible Encephalopathy Syndrome (PRES). Neurocrit Care. 2018;29:481-490. 3
  • [129] Datar S., Singh T., Rabinstein A.A., Fugate J.E., Hocker S. Long-term risk of seizures and epilepsy in patients with posterior reversible encephalopathy syndrome. Epilepsia. 2015;56:564-568. 4
  • [130] Hart L.A., Sibai B.M. Seizures in pregnancy: epilepsy, eclampsia, and stroke. Semin Perinatol. 2013;37:207-224. 4
  • [131] Liu S., Joseph K.S., Liston R.M., Bartholomew S., Walker M., León J.A. Incidence, risk factors, and associated complications of eclampsia. Obstet Gynecol. 2011;118:987-994. 5
  • [132] Berhan Y., Berhan A. Should magnesium sulfate be administered to women with mild pre-eclampsia? A systematic review of published reports on eclampsia. J Obstet Gynaecol Res. 2015;41:831-842. 6
  • [133] Douglas K.A., Redman C.W. Eclampsia in the United Kingdom. Bmj. 1994;309:1395-1400. 6966
  • [134] Brewer J., Owens M.Y., Wallace K., Reeves A.A., Morris R., Khan M. Posterior reversible encephalopathy syndrome in 46 of 47 patients with eclampsia. Am J Obstet Gynecol. 2013;208:468e1-e4686. 6
  • [135] Duley L., Henderson-Smart D. Magnesium sulphate versus diazepam for eclampsia. Cochrane Database Syst Rev. 2003;4:Cd000127.
  • [136] Duley L., Henderson-Smart D. Magnesium sulphate versus phenytoin for eclampsia. Cochrane Database Syst Rev. 2003;4:Cd000128.
  • [137] Altman D., Carroli G., Duley L., Farrell B., Moodley J., Neilson J. Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial. Lancet. 2002;359:1877-1890. 9321
  • [138] Nerenberg K.A., Park A.L., Vigod S.N., Saposnik G., Berger H., Hladunewich M.A. Long-term risk of a seizure disorder after eclampsia. Obstet Gynecol. 2017;130:1327-1333. 6
  • [139] Reynolds A.S., Claassen J. Treatment of seizures and postanoxic status epilepticus. Semin Neurol. 2017;37:33-39. 1
  • [140] Nielsen N., Wetterslev J., Cronberg T., Erlinge D., Gasche Y., Hassager C. Targeted temperature management at 33̊C versus 36̊C after cardiac arrest. N Engl J Med. 2013;369:2197-2206. 23
  • [141] Hofmeijer J., van Putten M.J. EEG in postanoxic coma: prognostic and diagnostic value. Clin Neurophysiol. 2016;127:2047-2055. 4
  • [142] Levy A., Chen R. Myoclonus: pathophysiology and treatment options. Curr Treat Options Neurol. 2016;18:21. 5
  • [143] Cronberg T. Should postanoxic status epilepticus be treated agressively? Yes! J Clin Neurophysiol. 2015;32:449-451. 6
  • [144] Beretta S., Coppo A., Bianchi E., Zanchi C., Carone D., Stabile A. Neurologic outcome of postanoxic refractory status epilepticus after aggressive treatment. Neurology. 2018;91:e2153-e2162. 23
  • [145] Leung H., Man C.B., Hui A.C., Kwan P., Wong K.S. Prognosticating acute symptomatic seizures using two different seizure outcomes. Epilepsia. 2010;51:1570-1579. 8